Comment on alemtuzumab and inclusion body myositis.

Authors	Steven A Greenberg
Journal	Brain : a journal of neurology (Brain) Vol. 133 Issue Pt 5 Pg. e135; author reply e136 (May 2010) ISSN: 1460-2156 [Electronic] England
PMID	19892769 (Publication Type: Letter, Comment)
Chemical References	Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Alemtuzumab
Topics	Alemtuzumab Antibodies, Monoclonal (therapeutic use) Antibodies, Monoclonal, Humanized Antibodies, Neoplasm (therapeutic use) Follow-Up Studies Humans Myositis, Inclusion Body (drug therapy) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!